An Individual Is Treated for Cystic Fibrosis by a Recombinant

An individual is treated for cystic fibrosis by a recombinant virus administered through an inhaler so the virus can ʺinfectʺ the cells lining the lungs. In the lungs, the recombinant DNA is incorporated into the patientʹs genomic DNA and produces a protein product that helps relieve the symptoms of the disease. Children born to this patient after the treatment can be expected to also carry the recombinant genes and benefit from them if they too suffer from cystic fibrosis.